Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Nausea × naldemedine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 1 Opioid-Induced Constipation 1 Nausea 1 Constipation 1

Interventions

Aprepitant 5 Dexamethasone 4 Ondansetron 3 Granisetron 3 Calcium Dobesilate 3 Palonosetron 2 Metoclopramide 2 naldemedine 1 dolasetron 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 alizapride 1 Tropisetron 1 Tablets 1 Duration of Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07038551 2025-07-02

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

International University of Health and Welfare

Phase 4 Recruiting

Opioid-Induced Constipation, Constipation, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡